Madhusoodanan S, Ting MB, Farah T, Ugur U. Psychiatric aspects of brain tumors: A review. World J Psychiatr 2015; 5(3): 273-285 [PMID: 26425442 DOI: 10.5498/wjp.v5.i3.273]
Corresponding Author of This Article
Subramoniam Madhusoodanan, MD, Associate Chair, Department of Psychiatry, St. John’s Episcopal Hospital, 327 Beach 19th Street, Far Rockaway, NY 11691, United States. sdanan@ehs.org
Research Domain of This Article
Psychiatry
Article-Type of This Article
Review
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Subramoniam Madhusoodanan, Department of Psychiatry, St. John’s Episcopal Hospital, Far Rockaway, NY 11691, United States
Subramoniam Madhusoodanan, Department of Psychiatry, SUNY Downstate Medical Center, Brooklyn, NY 11203, United States
Mark Bryan Ting, Community Behavioral Health Center, Fresno, CA 93720, United States
Mark Bryan Ting, Bio-Behavioral Medical Clinics, Fresno, CA 93711, United States
Tara Farah, Medical Student IV, Medical University of Lublin, 20-059 Lublin, Poland
Umran Ugur, Medical Student IV, Ross University School of Medicine, Miramar, FL 33027, United States
ORCID number: $[AuthorORCIDs]
Author contributions: All authors contributed to this paper.
Conflict-of-interest statement: The authors report no financial or other conflicts of interest in connection with this manuscript.
Open-Access: This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Correspondence to: Subramoniam Madhusoodanan, MD, Associate Chair, Department of Psychiatry, St. John’s Episcopal Hospital, 327 Beach 19th Street, Far Rockaway, NY 11691, United States. sdanan@ehs.org
Telephone: +1-718-8697248 Fax: +1-718-8698532
Received: May 6, 2015 Peer-review started: May 8, 2015 First decision: July 10, 2015 Revised: August 15, 2015 Accepted: September 7, 2015 Article in press: September 8, 2015 Published online: September 22, 2015 Processing time: 144 Days and 1.3 Hours
Abstract
Infrequently, psychiatric symptoms may be the only manifestation of brain tumors. They may present with mood symptoms, psychosis, memory problems, personality changes, anxiety, or anorexia. Symptoms may be misleading, complicating the clinical picture. A comprehensive review of the literature was conducted regarding reports of brain tumors and psychiatric symptoms from 1956-2014. Search engines used include PubMed, Ovid, Psych Info, MEDLINE, and MedScape. Search terms included psychiatric manifestations/symptoms, brain tumors/neoplasms. Our literature search yielded case reports, case studies, and case series. There are no double blind studies except for post-diagnosis/-surgery studies. Early diagnosis is critical for improved quality of life. Symptoms that suggest work-up with neuroimaging include: new-onset psychosis, mood/memory symptoms, occurrence of new or atypical symptoms, personality changes, and anorexia without body dysmorphic symptoms. This article reviews the existing literature regarding the diagnosis and management of this clinically complex condition.
Core tip: Psychiatric symptoms may rarely be the only presentation of a brain tumor. Any type of psychiatric symptoms can occur with brain tumors. Unfortunately, the symptoms generally do not have any localizing value. New onset psychosis, mood or memory symptoms, occurrence of new or atypical symptoms, personality changes and anorexia without body dysmorphic symptoms, suggest a work up including neuroimaging. Early diagnosis is critical for improved quality of life for the patient.
Citation: Madhusoodanan S, Ting MB, Farah T, Ugur U. Psychiatric aspects of brain tumors: A review. World J Psychiatr 2015; 5(3): 273-285
The majority of large studies discussing brain neoplasms and psychiatric symptoms date back to the 1930’s[1]. Since psychiatric nomenclature and disease parameters change constantly, it is difficult to analyze this topic in a consistent manner.
Brain tumors are relatively common with an annual incidence of 9 per 100000 for primary brain tumors and 8.3 per 100000 for metastatic brain tumors. Brain tumors may be classified based on their histopathologic characteristics or anatomical location. There are two types of tumors: ones that are primary, originating from the brain tissue, and ones that metastasize to numerous locations throughout the brain. Because of this, metastatic tumors often present with more neuropsychiatric symptoms. The most common primary brain tumors are gliomas, which are divided into several types: astrocytomas, oligodendrogliomas, and ependymomas. The groups of brain tumors that are not from the glial tissue include meningiomas, schwannomas, craniopharyngiomas, germ cell tumors, pituitary adenomas, and pineal region tumors. Majority of all brain tumors are gliomas, accounting for 40%-55%. Tumors metastasizing to the brain account for 15%-25% of all brain tumors[2].
Most brain tumors present with specific neurologic signs due to mass effect. However, in rare cases they may present primarily with psychiatric symptoms. A study by Keschner et al[3] reported that 78% of 530 patients with brain tumors had psychiatric symptoms. However, 18% of the 530 presented only with these symptoms as the first clinical manifestation of a brain tumor. Due to the neuronal connections of the brain, a lesion in one region may manifest a multitude of symptoms depending on the function of the underlying neuronal foci. Symptoms of brain lesions depend on the functions of the networks underlying the affected areas[1]. For instance, a significant association has been found between anorexia symptoms and hypothalamic tumors, a probable association between psychotic symptoms and pituitary tumors, memory symptoms and thalamic tumors, and mood symptoms and frontal tumors[4].
Management of brain tumors consists of surgical resection of the tumor, stereotactic radiosurgery, radiotherapy, and chemotherapy. Treatment of the psychiatric symptoms caused by brain tumors depends on the presenting symptoms and includes antidepressants, antipsychotics, mood stabilizers, and anxiolytics[1].
Although there may be an association between some tumor locations and psychiatric symptoms, it is difficult to predict the symptoms based on the location or vice versa. This paper will explore the diverse manifestations, diagnosis, and management of brain tumors that present primarily with psychiatric symptoms.
LITERATURE REVIEW
A comprehensive review of the literature was conducted regarding reports of brain tumors and psychiatric symptoms from 1956-2014. Search engines used include PubMed, Ovid, Psych Info, MEDLINE, and MedScape. Search terms included psychiatric manifestations/symptoms, brain tumors/neoplasms. Our literature search yielded case reports, case studies, and case series. There are no double blind studies except for post-diagnosis/-surgery studies.
We found 172 cases with psychiatric symptoms. Psychiatric symptoms were assigned to 7 main categories: depressive symptoms, apathy, manic symptoms, psychosis, personality changes, eating disorders, and a miscellaneous category for the less frequently encountered symptoms. Each category will be discussed. Some reports may be included in more than one category due to combination of symptoms.
Depression may be seen in different stages (before, during or after diagnosis/treatment) of brain tumors. Depression was reported in 2.5%-15.4% of primary brain tumors[5]. According to Mainio et al[6], depression was found in 44% of all brain tumor patients, primary and metastatic, and was associated with functional impairment, cognitive dysfunction, reduced quality of life, and reduced survival[7]. It was also noted that depression was more commonly found in frontal lobe tumors[8-10]. More specifically left frontal lobe tumors were more frequently associated with depression and akinesia[11].
Apathy must be distinguished from major depressive disorder and chronic fatigue syndrome. Patients presenting with apathy when asked about their mood, state that they are not depressed, but instead have chronic fatigue and lack of motivation[12]. This may be associated with a functional disconnection between the frontal lobe and paralimbic areas, or damage in these areas[13,14]. Levy et al[15] suggests that apathy is common in neurodegenerative disorders and is independent of depression. The diagnostic criteria for apathy suggested by Starkstein et al[16] include lack of motivation, diminished goal-directed behavior (lack of effort, or dependency on others to structure activity), diminished goal-directed cognition (lack of interest in learning new things or in new experiences, or lack of concern about one’s personal problems), or diminished emotions (unchanging affect, or lack of emotional responsivity to positive or negative events).
Some residual psychiatric disturbance following resection
In addition to depression, patients with brain tumors can also present with other mood symptoms, such as mania. There are reports which show that while depression was associated with left frontal tumors, mania was found more commonly with right frontal tumors presenting with characteristics such as euphoria and underestimation of the significance of their illness[11]. Right hemisphere lesions have been reported to present as manic symptoms[17-19].
Another common psychiatric presentation of brain tumors is hallucinations and psychosis. Madhusoodanan et al[4] reported that while mood symptoms are the most common, being reported in 36% of the cases, psychotic symptoms were found in 22% of patients. In these cases of psychotic symptoms, the tumors were found in cerebral cortical, pituitary, pineal and posterior locations. Among these, pituitary gland was the most common location for psychotic symptoms. However, in another study, temporal lobe tumors were closely related to psychotic manifestations[8].
Rage attacks, Bulimia, uninhibited and brutal sexual behavior, periods of depression with suicide attempts
Fronto-temporal
Astrocytoma
Frontal lobe lesions and ventricular cysts may present with personality changes. This may include disinhibition, hypersexuality, and aggressive behaviors.
Weight loss and decreased appetite are associated with different types of malignancies, and in patients with brain tumors it may be among the first warning signs. This may be mistaken for symptoms of anorexia nervosa, particularly in young females, and can lead to a misdiagnosis. A review by Madhusoodanan et al[4] on associations between tumor locations and psychiatric symptoms concluded that while anorexic symptoms may be a result of tumors in numerous locations in the brain, hypothalamic neoplasms most commonly present as anorexia symptoms.
Aggressive behavior, cognitive impairment on background of chronic alcohol abuse and head injuries
Left temporal
Astrocytoma
There are some cases of patients with brain tumors who present with a more ambiguous psychiatric history and progression of illness. Feng et al[20] described an 86-year-old female who presented with anomic aphasia. The patient reportedly had difficulty naming familiar objects and people for month. Her neurological exam was normal and she did not have any symptoms aside from the anomic aphasia. A brain computed tomography (CT) and magnetic resonance imaging (MRI) showed a large tumor in the left temporal lobe, compressing the left lateral ventricle and causing a midline shift. She underwent surgical resection of the tumor and radiotherapy. Pathology reports showed that the tumor was a glioblastoma multiforme. In this case, surgery and radiotherapy did not result in resolution of the anomic aphasia.
Among other less common and atypical psychiatric manifestations of brain tumor is a case of pathological laughter reported by Tsutsumi et al[21]. A 60-year-old female presented with abnormal laughter and left-hemiparesis. Her laughter was induced by non-specific stimuli and lasted for a few minutes. The MRI showed a ring-enhanced lesion in the subcortical area of the right frontal lobe along with extensive perifocal brain edema. Upon total resection of the tumor, glioblastoma multiforme was diagnosed. Two weeks post-operative follow-up showed resolution of her pathological laughter and hemiparesis.
DIAGNOSIS
Brain tumors as the primary cause of psychiatric symptoms are a rare occurrence. The rarity of this condition, insidiousness of the disease process, vague symptomatology, variety of signs pointing to several causative factors all contribute to the diagnostic challenges. Diagnosis of psychiatric symptoms being secondary to brain tumors starts from having the clinical suspicion. Early diagnosis is critical with regards to further treatment and better quality of life[1].
A thorough medical history and physical examination may assist in the diagnosis. Subtle clues that could otherwise be missed include neurologic signs: apraxia, visual field deficits, and anomia. Personality changes, sleep disturbances, apathy, weight loss, anorexia, or faltering concentration may be the first presentation of the illness. Further clues that suggest the presence of brain tumors may include psychiatric symptoms that do not fall into distinct diagnostic categories or atypical symptoms, symptoms that are refractory to treatment, and recurrence of previously controlled symptoms where other contributory factors (such as non-adherence to treatment, acute stressors, or medication changes) have been ruled out[1].
Neuroimaging is the primary diagnostic modality used to visualize the presence of brain tumors. CT and MRI are used for anatomical assessments. Magnetic resonance spectroscopy is used for the relative quantification of metabolites in different brain locations. Studies of neuronal activity related to local cerebral blood flow are done by functional MRI (fMRI). Positron emission tomography and single-photon emission computed tomography provide images by use of radionuclides[22]. For the purpose of this article, we will focus on the anatomical assessments that are routinely used in clinical practice. CT remains the modality of choice for trauma and acute hemorrhage. Its other advantages include: greater availability, fewer contraindications, and less expense. MRI offers higher resolution and is useful in evaluating necrosis, hemorrhage, cysts, tumors, and white-matter changes. It is generally superior to CT in visualizing brain tumors or other soft-tissue lesions. Functional studies are mostly used in the research setting and presently do not appear to have major advantages over CT and MRI for routine clinical setting. This may change with further refinements and clinical utility[22].
Madhusoodanan et al[1] recommended that neuroimaging be considered in the following conditions: new-onset psychosis, new-onset mood/memory symptoms, occurrence of new or atypical symptoms, new-onset personality changes, and anorexia without body dysmorphic symptoms. Conditions wherein neuroimaging may or may not be required include recurrence of previously controlled psychiatric symptoms and patients that are refractory to treatment[1].
Neuropsychological testing is useful in evaluating cognitive and neuropsychological dysfunction, in documenting changes pre- and post-treatment, and in monitoring the effectiveness of rehabilitative efforts[2].
MANAGEMENT
Removal of the tumor may completely resolve the psychiatric or behavioral symptoms. Otherwise, decreasing the size of the tumor or halting its growth may also decrease these symptoms. Additionally, treating the acute mass effects such as increased intracranial pressure or hydrocephalus may improve cognitive functioning and decrease behavioral symptoms[2].
Neuropsychiatric and behavioral symptoms can persist or worsen after these interventions. Pharmacological and psychotherapeutic measures can be instituted to improve the functioning and quality of life[2].
Pharmacological management follows general therapeutic principles of tumor-free patients with similar symptoms. However, patients with brain tumors may have increased susceptibility for delirium, seizures, medication side effects, and drug-drug interactions.
Antidepressants may be beneficial in patients presenting primarily with depressive symptoms. Selective serotonin reuptake inhibitors (SSRIs) have a favorable side effect profile and less potential to cause delirium. Maprotiline and bupropion appear to have higher risk for seizures[23]. Methylphenidate has also been shown to be effective in patients with secondary depression. It was well tolerated and did not appear to have an increased risk for seizures. It was also found to be effective in patients with apathy syndrome aside from depression[24].
Mood stabilizers are useful in treating manic symptoms. Lithium may cause delirium and lower seizure threshold. Valproate, carbamazepine, oxcarbazepine, benzodiazepines, and gabapentin, having anticonvulsant properties, may be preferable alternatives[2]. A recent review explored possible neuroprotective effects of lithium in patients with brain cancer, especially when treated with radiation. Possible targets of lithium may include excitotoxicity, excessive apoptosis, reduced neurogenesis, and senescence of growth and regeneration. This effect has been shown in preliminary studies, but more research is required to confirm its benefits and clinical utility[25].
Antipsychotics may be used for treating psychotic syndromes with hallucinations, delusions, and disturbances in thought content and processes. First-generation antipsychotics were more widely used. Lower potency antipsychotics like chlorpromazine and thioridazine may be associated with increased risk for seizures and delirium. High-potency antipsychotics such as fluphenazine and haloperidol have lesser risk for seizure and delirium. First-generation antipsychotics like haloperidol and fluphenazine have a higher potential for extrapyramidal symptoms. This can be minimized by lowering the dosages or the addition of antiparkinsonian agents such as benztropine or trihexyphenidyl. However, addition of these agents also increases the risk for anticholinergic delirium. The second-generation antipsychotics may be preferred because of lower incidence of some of these side-effects. Effectiveness of these agents has been noted in some case reports[26,27]. However, clozapine and olanzapine are also associated with higher risk for seizures and delirium[28].
Other treatment modalities include electro-convulsive therapy (ECT). This may be given consideration in cases of refractory depression. Brain tumors without increased intracranial pressure (ICP) or edema can be treated safely with ECT[29-32] when appropriate precautions have been taken. Daily neurological evaluations are of paramount importance as deterioration may be subtle. High-risk patients are those with presence of large mass or multiple masses, increased intracranial pressure, edema, or mass effect. In these patients, ECT may be considered only if they are severely ill, or there is risk for harm to self or others, and other options have failed. Measures to reduce edema and the increase in ICP should be undertaken. Regardless of the risks of ECT, all patients undergoing this treatment should have ongoing consultation with the neurologist/neurosurgeon. Additionally, changes in the lesion should be taken into account during maintenance treatments, as low-risk patients may progress to high-risk[33].
Psychotherapy is also an important treatment modality. This helps to improve overall functional status, interpersonal and psychosocial stressors, and emotional and cognitive status. Anxiety and depressive symptoms are frequently present and may benefit from supportive and cognitive therapy, and psychoeducation. This is supported by a study which found that the presence of depressive symptoms was the most important predictor of quality of life among patients with brain tumors[34]. It is also important to improve coping strategies and identify maladaptive defenses that may interfere with somatic treatments[2].
DISCUSSION
Diagnosis and treatment of psychiatric symptoms of brain tumors are challenging. At initial presentation, patients may have a variety of symptoms or a clinical picture that do not fit into a diagnostic category. Symptoms may be vague, such as apathy syndrome or personality changes, or symptoms that are refractory to treatment. Psychiatric symptoms may be the only presenting symptoms of a brain tumor. These symptoms tend not to be localized to specific anatomical regions and tumors are not confined to specific subdivisions. Tumors also exert effects by pressure, edema, and diaschisis (affecting connections to distant areas of the brain). Thus, psychiatric symptoms generally have no localizing value. A possible exception as previously discussed, is hypothalamic tumors that present with anorexia without distorted body image. Neuroimaging, pituitary hormone levels, and ophthalmologic evaluation are recommended based on the symptomatology to rule out the presence of a tumor[1,4].
Various studies describe the impact of tumor location and the variety of symptoms. Dorsolateral tumors lead to difficulties with organization and planning. Orbito-frontal tumors cause disinhibition, and medial frontal tumors cause apathy and abulia. Frontal tumors may exhibit personality changes in the patient. Diencephalic and pituitary lesions lead to vegetative symptoms. More specifically, diencephalic lesions manifest hypersomnic and hyperphagic variants of depressive disorders[8-10,35,36].
A thorough history and physical examination, high degree of clinical suspicion, and neuroimaging are keys to the diagnosis. A review[37] was conducted on the clinical- and cost-effectiveness of structural imaging (by use of CT or MRI) in patients with psychosis, especially that of first-episode psychosis. It concluded that structural neuroimaging adds little clinical information not suspected on history and physical examination that would influence management. Routine neuroimaging is not recommended.
Brain tumors may be primary or secondary, and are treated accordingly either by surgery, radiation, or chemotherapy. After the treatment of the tumor, psychiatric symptoms may either resolve or persist. From our clinical experience, we advocate that the treatment of psychiatric symptoms may begin before the treatment of the brain tumor, to improve the quality of life and coping skills. The psychotropics may be tapered gradually and discontinued after the tumor treatment. If psychiatric symptoms recur, psychotropics may be reinstated.
Studies of anxiety, depression, and somatic symptoms in brain tumors are complicated because it is unclear whether they are caused by the tumor or is a psychological response to the stress secondary to the diagnosis or treatment. Compounding the clinical conundrum is the lack of large controlled studies evaluating the psychiatric symptoms of brain tumors or their treatment modalities. Due to the relative rarity of this presentation and the wide array of manifestations, information regarding treatment is mostly derived from case reports or case series. Furthermore, the descriptions of psychiatric symptoms are not uniform in the literature. All these factors contribute to the difficulties in the analysis and extrapolation of available information. Treatment options include pharmacotherapy, psychotherapy, and ECT as discussed earlier.
A review that attempted to delineate the role of antidepressants in patients with brain tumors was unable to make recommendations due to lack of appropriate studies and cautions about the assumption of efficacy in this patient population[38]. With regards to safety, a study of SSRIs in patients with glioblastoma multiforme found neither any increased toxicity nor adverse effects on survival[39]. Methylphenidate has shown some evidence of efficacy in improving cognitive function and motivation. The side effects were minimal[24]. However, a more recent prospective, placebo-controlled trial of prophylactic d-threo-methylphenidate did not show any improvement in quality of life, with the main outcome measure being improvements in fatigue[40].
Continued treatment for persistent psychiatric symptoms is also complicated by the potential for delirium and seizures, possible side effects, drug-drug interactions, and status of the tumor and its treatment. Steroids may be associated with depression and psychosis. It is important that the treatment should be based on a multi-disciplinary team approach. Clinical specialists involved in the treatment should work closely and be aware of these issues with continued treatment, rehabilitation, and quality of life.
CONCLUSION
Psychiatric symptoms may be the only presenting feature of brain tumors. Thorough history and medical examination with a high index of suspicion are important for early diagnosis. Neuroimaging should be considered in patients presenting with new-onset psychosis or mood/memory symptoms, occurrence of new or atypical symptoms, personality changes, and anorexia without body dysmorphic symptoms. Treatment is geared towards the tumor, its complications, and the psychiatric symptoms. Management of persistent psychiatric symptoms is based on extrapolation of limited evidence, assessment of risk vs benefits, and understanding of potential complications related to the disease and concomitant therapy. Further investigation is needed to improve our understanding of the mechanisms by which tumors produce psychiatric symptoms. This may lead to improved understanding of the mechanisms of psychiatric disorders, advanced diagnostic modalities, better categorization of symptom constructs, and prospective trials for the management of the psychiatric symptoms in patients with brain tumors. With improvements in imaging techniques and diagnostic categorization of psychiatric symptoms, studies of correlation of anatomic location or neuronal functional groups and psychiatric symptoms may yield associations not previously found.
Footnotes
P- Reviewer: Lu RB S- Editor: Ji FF L- Editor: A E- Editor: Wu HL
Mainio A, Hakko H, Timonen M, Niemelä A, Koivukangas J, Räsänen P. Depression in relation to survival among neurosurgical patients with a primary brain tumor: a 5-year follow-up study.Neurosurgery. 2005;56:1234-1241; discussion 1241-1442.
[PubMed] [DOI][Cited in This Article: ]
Filley CM, Kleinschmidt-DeMasters BK. Neurobehavioral presentations of brain neoplasms.West J Med. 1995;163:19-25.
[PubMed] [DOI][Cited in This Article: ]
Wellisch DK, Kaleita TA, Freeman D, Cloughesy T, Goldman J. Predicting major depression in brain tumor patients.Psychooncology. 2002;11:230-238.
[PubMed] [DOI][Cited in This Article: ]
Belyi BI. Mental impairment in unilateral frontal tumours: role of the laterality of the lesion.Int J Neurosci. 1987;32:799-810.
[PubMed] [DOI][Cited in This Article: ]
Weitzner MA, Kanfer S, Booth-Jones M. Apathy and pituitary disease: it has nothing to do with depression.J Neuropsychiatry Clin Neurosci. 2005;17:159-166.
[PubMed] [DOI][Cited in This Article: ]
Craig AH, Cummings JL, Fairbanks L, Itti L, Miller BL, Li J, Mena I. Cerebral blood flow correlates of apathy in Alzheimer disease.Arch Neurol. 1996;53:1116-1120.
[PubMed] [DOI][Cited in This Article: ]
Levy ML, Cummings JL, Fairbanks LA, Masterman D, Miller BL, Craig AH, Paulsen JS, Litvan I. Apathy Is Not Depression.J Neuropsychiatry Clin Neurosci. 1998;10:314-319.
[PubMed] [DOI][Cited in This Article: ]
Starkstein SE, Petracca G, Chemerinski E, Kremer J. Syndromic validity of apathy in Alzheimer’s disease.Am J Psychiatry. 2001;158:872-877.
[PubMed] [DOI][Cited in This Article: ]
Jamieson RC, Wells CE. Manic psychosis in a patient with multiple metastatic brain tumors.J Clin Psychiatry. 1979;40:280-283.
[PubMed] [DOI][Cited in This Article: ]
Starkstein SE, Boston JD, Robinson RG. Mechanisms of mania after brain injury. 12 case reports and review of the literature.J Nerv Ment Dis. 1988;176:87-100.
[PubMed] [DOI][Cited in This Article: ]
Tsutsumi S, Yasumoto Y, Ito M. Pathological laughter caused by frontal glioblastoma: case report.Neurol Med Chir (Tokyo). 2008;48:307-310.
[PubMed] [DOI][Cited in This Article: ]
Meyers CA, Weitzner MA, Valentine AD, Levin VA. Methylphenidate therapy improves cognition, mood, and function of brain tumor patients.J Clin Oncol. 1998;16:2522-2527.
[PubMed] [DOI][Cited in This Article: ]
Canuet L, Ikezawa K, Ishii R, Aoki Y, Iwase M, Takeda M. Schizophrenia-like psychosis associated with right-parietal meningioma.J Neuropsychiatry Clin Neurosci. 2011;23:E36.
[PubMed] [DOI][Cited in This Article: ]
Stoudemire A, Fogel BS, Gulley LR, Moran MG. Psychopharmacology in the medical patient.Psychiatric Care of the Medical Patient. New York: Oxford University Press 1993; 155-206.
[PubMed] [DOI][Cited in This Article: ]
Greenberg LB, Mofson R, Fink M. Prospective electroconvulsive therapy in a delusional depressed patient with a frontal meningioma. A case report.Br J Psychiatry. 1988;153:105-107.
[PubMed] [DOI][Cited in This Article: ]
Ghaziuddin N, DeQuardo JR, Ghaziuddin M, King CA. Electroconvulsive treatment of a bipolar adolescent postcraniotomy for brain stem astrocytoma.J Child Adolesc Psychopharmacol. 1999;9:63-69.
[PubMed] [DOI][Cited in This Article: ]
Kohler CG, Burock M. ECT for psychotic depression associated with a brain tumor.Am J Psychiatry. 2001;158:2089.
[PubMed] [DOI][Cited in This Article: ]
Rasmussen KG, Perry CL, Sutor B, Moore KM. ECT in patients with intracranial masses.J Neuropsychiatry Clin Neurosci. 2007;19:191-193.
[PubMed] [DOI][Cited in This Article: ]
Pelletier G, Verhoef MJ, Khatri N, Hagen N. Quality of life in brain tumor patients: the relative contributions of depression, fatigue, emotional distress, and existential issues.J Neurooncol. 2002;57:41-49.
[PubMed] [DOI][Cited in This Article: ]
Albon E, Tsourapas A, Frew E, Davenport C, Oyebode F, Bayliss S, Arvanitis T, Meads C. Structural neuroimaging in psychosis: a systematic review and economic evaluation.Health Technol Assess. 2008;12:iii-iv, ix-163.
[PubMed] [DOI][Cited in This Article: ]
Madhusoodanan S, Sinha A, Moise D. Chapter VIII: Psychiatric Manifestations of Brain Tumors.Trends in Brain Cancer Research. New York: Nova Science Publishers Inc 2006; 281-301.
[PubMed] [DOI][Cited in This Article: ]
Zivković N, Marković M, Mihajlović G, Jovanović M. Surgical treatment of intradiploic epidermoid cyst treated as depression.Srp Arh Celok Lek. 2014;142:67-71.
[PubMed] [DOI][Cited in This Article: ]
Cheema FA, Badr A, Iqbal J. Glioblastoma multiforme presenting as treatment-resistant depression.J Neuropsychiatry Clin Neurosci. 2010;22:123.E26.
[PubMed] [DOI][Cited in This Article: ]
Bunevicius A, Deltuva VP, Deltuviene D, Tamasauskas A, Bunevicius R. Brain lesions manifesting as psychiatric disorders: eight cases.CNS Spectr. 2008;13:950-958.
[PubMed] [DOI][Cited in This Article: ]
Habermeyer B, Weiland M, Mager R, Wiesbeck GA, Wurst FM. A clinical lesson: glioblastoma multiforme masquerading as depression in a chronic alcoholic.Alcohol Alcohol. 2008;43:31-33.
[PubMed] [DOI][Cited in This Article: ]
Oreskovic NM, Strother CG, Zibners LM. An unusual case of a central nervous system tumor presenting as a chief complaint of depression.Pediatr Emerg Care. 2007;23:486-488.
[PubMed] [DOI][Cited in This Article: ]
Moise D, Madhusoodanan S. Psychiatric symptoms associated with brain tumors: a clinical enigma.CNS Spectr. 2006;11:28-31.
[PubMed] [DOI][Cited in This Article: ]
Madhusoodanan S, Danan D, Brenner R, Bogunovic O. Brain tumor and psychiatric manifestations: a case report and brief review.Ann Clin Psychiatry. 2004;16:111-113.
[PubMed] [DOI][Cited in This Article: ]
Kaplan CP, Miner ME. Anxiety and depression in elderly patients receiving treatment for cerebral tumours.Brain Inj. 1997;11:129-135.
[PubMed] [DOI][Cited in This Article: ]
Kugaya A, Fujikawa T, Yoshimura Y, Uchitomi Y, Yamawaki S, Hirohata T. Ependymal cyst and psychiatric symptoms.J Neurol Neurosurg Psychiatry. 1996;60:461-462.
[PubMed] [DOI][Cited in This Article: ]
Chipkevitch E, Fernandes AC. Hypothalamic tumor associated with atypical forms of anorexia nervosa and diencephalic syndrome.Arq Neuropsiquiatr. 1993;51:270-274.
[PubMed] [DOI][Cited in This Article: ]
Fulton JD, Duncan G, Caird FI. Psychiatric presentation of intracranial tumour in the elderly.Int J Geriatr Psychiatry. 1992;7:411-418.
[PubMed] [DOI][Cited in This Article: ]
Goodman AJ, Kumar A. Case report: Frontal lobe tumor presenting as late onset depression.Int J Geriatr Psychiatry. 1992;7:377-380.
[PubMed] [DOI][Cited in This Article: ]
Tanaghow A, Lewis J, Jones GH. Anterior tumour of the corpus callosum with atypical depression.Br J Psychiatry. 1989;155:854-856.
[PubMed] [DOI][Cited in This Article: ]
Upadhyaya AK, Sud PD. Psychiatric presentation of third ventricular colloid cyst. A case report.Br J Psychiatry. 1988;152:567-569.
[PubMed] [DOI][Cited in This Article: ]
Summerfield DA. Psychiatric vulnerability and cerebellar haemangioblastoma. A case report.Br J Psychiatry. 1987;150:858-860.
[PubMed] [DOI][Cited in This Article: ]
Ghadirian AM, Gauthier S, Bertrand S. Anxiety attacks in a patient with a right temporal lobe meningioma.J Clin Psychiatry. 1986;47:270-271.
[PubMed] [DOI][Cited in This Article: ]
Maurice-Williams RS, Sinar EJ. Depression caused by an intracranial meningioma relieved by leucotomy prior to diagnosis of the tumour.J Neurol Neurosurg Psychiatry. 1984;47:884-885.
[PubMed] [DOI][Cited in This Article: ]
Fisher R, Harper C. Depressive illness as a presentation of primary lymphoma of the central nervous system.Aust N Z J Psychiatry. 1983;17:84-90.
[PubMed] [DOI][Cited in This Article: ]
Barbizet J, Poirier J. Frontotemporal astrocytoma. Anatomo-clinical study and discussion of behavior disorders.Ann Med Psychol (Paris). 1982;140:1015-1022.
[PubMed] [DOI][Cited in This Article: ]
Khuan TC, Dass D, Majeed H. Psychiatric presentation of thalamic tumour - a case report.Med J Malaysia. 1979;34:38-41.
[PubMed] [DOI][Cited in This Article: ]
Burkle FM, Lipowski ZJ. Colloid cyst of the third ventricle presenting as psychiatric disorder.Am J Psychiatry. 1978;135:373-374.
[PubMed] [DOI][Cited in This Article: ]
Carlson RJ. Frontal lobe lesions masquerading as psychiatric disturbances.Can Psychiatr Assoc J. 1977;22:315-318.
[PubMed] [DOI][Cited in This Article: ]
Scherrer P, Quiniou-Vidalenc M. Psychiatric symptomatology of cerebral tumors apropos of 2 cases.Ann Med Psychol (Paris). 1974;1:98-106.
[PubMed] [DOI][Cited in This Article: ]
Aydin EF, Ozan E. Transience of dysexecutive syndrome but permanence of motor deficits in the course of recurrent subfrontal meningioma.J Neuropsychiatry Clin Neurosci. 2013;25:E19.
[PubMed] [DOI][Cited in This Article: ]
Bhatia MS, Srivastava S, Jhanjee A, Oberoi A. Colloid cyst presenting as recurrent mania.J Neuropsychiatry Clin Neurosci. 2013;25:E01-E02.
[PubMed] [DOI][Cited in This Article: ]
Yetimalar Y, Iyidogan E, Basoglu M. Secondary mania after pontin cavernous angioma.J Neuropsychiatry Clin Neurosci. 2007;19:344-345.
[PubMed] [DOI][Cited in This Article: ]
Mazure CM, Leibowitz K, Bowers MB. Drug-responsive mania in a man with a brain tumor.J Neuropsychiatry Clin Neurosci. 1999;11:114-115.
[PubMed] [DOI][Cited in This Article: ]
Mark M, Modai I, Aizenberg D, Heilbronn Y, Elizur A. Bipolar disorder associated with an acoustic neurinoma.Hosp Community Psychiatry. 1991;42:1258-1260.
[PubMed] [DOI][Cited in This Article: ]
Parisis D, Poulios I, Karkavelas G, Drevelengas A, Artemis N, Karacostas D. Peduncular hallucinosis secondary to brainstem compression by cerebellar metastases.Eur Neurol. 2003;50:107-109.
[PubMed] [DOI][Cited in This Article: ]
Maiuri F, Iaconetta G, Sardo L, Buonamassa S. Peduncular hallucinations associated with large posterior fossa meningiomas.Clin Neurol Neurosurg. 2002;104:41-43.
[PubMed] [DOI][Cited in This Article: ]
Miyazawa T, Fukui S, Otani N, Tsuzuki N, Katoh H, Ishihara S, Nawashiro H, Wada K, Shima K. Peduncular hallucinosis due to a pineal meningioma. Case report.J Neurosurg. 2001;95:500-502.
[PubMed] [DOI][Cited in This Article: ]
Vardar E, Tuğlu C, Tekin S. Genel tıbbi bir duruma bağlı psikotik bozukluk: Araknoid kist ve şizofreni benzeri psikoz-vaka sunumu.Anadolu Psikiyatri Dergisi. 2000;1:246-251.
[PubMed] [DOI][Cited in This Article: ]
Werring DJ, Marsden CD. Visual hallucinations and palinopsia due to an occipital lobe tuberculoma.J Neurol Neurosurg Psychiatry. 1999;66:684.
[PubMed] [DOI][Cited in This Article: ]
Carson BS, Weingart JD, Guarnieri M, Fisher PG. Third ventricular choroid plexus papilloma with psychosis. Case report.J Neurosurg. 1997;87:103-105.
[PubMed] [DOI][Cited in This Article: ]
Ball C. The psychiatric presentation of a cerebellopontine angle tumour.Irish J Psychol Medicine. 1996;13:21-23.
[PubMed] [DOI][Cited in This Article: ]
Okada F, Aida T, Abe H. Schizophrenic Symptoms Induced by a Tumor of the Left Basal Ganglia with Imilateral Cerebral Hemikrophy.Ann Clin Psychiatry. 1992;4:105-109.
[PubMed] [DOI][Cited in This Article: ]
Trabert W, Reif J. Anorexia nervosa, epileptic seizures and schizophreniform psychosis in temporo-basal angioma.Nervenarzt. 1990;61:57-60.
[PubMed] [DOI][Cited in This Article: ]
Nagaratnam N, Ghougassian DE, Wong K, Walker S. Psychiatric presentation of a venous angioma of the frontal lobe.Br J Clin Pract. 1990;44:34-35.
[PubMed] [DOI][Cited in This Article: ]
Binder RL. Neurologically silent brain tumors in psychiatric hospital admissions: three cases and a review.J Clin Psychiatry. 1983;44:94-97.
[PubMed] [DOI][Cited in This Article: ]
Dunn DW, Weisberg LA, Nadell J. Peduncular hallucinations caused by brainstem compression.Neurology. 1983;33:1360-1361.
[PubMed] [DOI][Cited in This Article: ]
Soulairac A, Viala-Parizot A, Vedrenne C. A case of peduncular hallucinosis following development of an earlier tumor process.Ann Med Psychol (Paris). 1979;137:882-888.
[PubMed] [DOI][Cited in This Article: ]
Buchanan DC, Abram HS. Psychotic behavior resulting from a lateral ventricle meningioma: a case report.Dis Nerv Syst. 1975;36:400-401.
[PubMed] [DOI][Cited in This Article: ]
Lajara-Nanson WA. Neuropsychiatric manifestations of a third ventricular colloid cyst.W V Med J. 2000;96:512-513.
[PubMed] [DOI][Cited in This Article: ]
Paul RH, Piatt AL, Whelihan WM, Malloy PF. Neuropsychological and magnetic resonance imaging abnormalities associated with a plasmacytoma of the frontal dura: a case report.Neuropsychiatry Neuropsychol Behav Neurol. 2000;13:143-147.
[PubMed] [DOI][Cited in This Article: ]
Jones AM. Psychiatric presentation of a third ventricular colloid cyst in a mentally handicapped woman.Br J Psychiatry. 1993;163:677-678.
[PubMed] [DOI][Cited in This Article: ]
Houy E, Debono B, Dechelotte P, Thibaut F. Anorexia nervosa associated with right frontal brain lesion.Int J Eat Disord. 2007;40:758-761.
[PubMed] [DOI][Cited in This Article: ]
Lin L, Liao SC, Lee YJ, Tseng MC, Lee MB. Brain tumor presenting as anorexia nervosa in a 19-year-old man.J Formos Med Assoc. 2003;102:737-740.
[PubMed] [DOI][Cited in This Article: ]
Wolańczyk T, Komender J, Brzozowska A. Catatonic syndrome preceded by symptoms of anorexia nervosa in a 14-year-old boy with arachnoid cyst.Eur Child Adolesc Psychiatry. 1997;6:166-169.
[PubMed] [DOI][Cited in This Article: ]
Climo LH. Anorexia nervosa associated with hypothalamic tumor: the search for clinical-pathological correlations.Psychiatr J Univ Ott. 1982;7:20-25.
[PubMed] [DOI][Cited in This Article: ]
Weller RA, Weller EB. Anorexia nervosa in a patient with an infiltrating tumor of the hypothalamus.Am J Psychiatry. 1982;139:824-825.
[PubMed] [DOI][Cited in This Article: ]
Swann I. Anorexia nervosa--a difficult diagnosis in boys. Illustrated by three cases.Practitioner. 1977;218:424-427.
[PubMed] [DOI][Cited in This Article: ]
White JH, Kelly P, Dorman K. Clinical picture of atypical anorexia nervosa associated with hypothalamic tumor.Am J Psychiatry. 1977;134:323-325.
[PubMed] [DOI][Cited in This Article: ]
Hoffmann K, Kretschmar B, Buller V, Kermer P. Craniopharyngioma resulting in pituitary gland insufficiency and coma in an adult with intellectual disability and severe challenging behavior.J Neuropsychiatry Clin Neurosci. 2010;22:451-j.e18-451.e19.
[PubMed] [DOI][Cited in This Article: ]
Rosenzweig I, Bodi I, Selway RP, Crook WS, Moriarty J, Elwes RD. Paroxysmal ictal phonemes in a patient with angiocentric glioma.J Neuropsychiatry Clin Neurosci. 2010;22:123.E18-123.E20.
[PubMed] [DOI][Cited in This Article: ]
Sokolski KN, Denson TF. Exacerbation of mania secondary to right temporal lobe astrocytoma in a bipolar patient previously stabilized on valproate.Cogn Behav Neurol. 2003;16:234-238.
[PubMed] [DOI][Cited in This Article: ]
Burns JM, Swerdlow RH. Right orbitofrontal tumor with pedophilia symptom and constructional apraxia sign.Arch Neurol. 2003;60:437-440.
[PubMed] [DOI][Cited in This Article: ]
Daigneault S, Braun CM, Montes JL. Hypothalamic hamartoma: detailed presentation of a case.Encephale. 1999;25:338-344.
[PubMed] [DOI][Cited in This Article: ]
Konovalov AN, Dobrokhotova TA, Voronina IA, Urakov SV. Case of Korsakoff syndrome and colloid cyst of the 3rd ventricle.Zh Nevrol Psikhiatr Im S S Korsakova. 1998;98:49-51.
[PubMed] [DOI][Cited in This Article: ]
Caplan R, Comair Y, Shewmon DA, Jackson L, Chugani HT, Peacock WJ. Intractable seizures, compulsions, and coprolalia: a pediatric case study.J Neuropsychiatry Clin Neurosci. 1992;4:315-319.
[PubMed] [DOI][Cited in This Article: ]
Ribeiro SA, Oliveira-Souza R, Alvarenga H. Bonnet syndrome and posterior parasagittal tumor: clues to neural mechanisms.Arq Neuropsiquiatr. 1989;47:230-234.
[PubMed] [DOI][Cited in This Article: ]
Durst R, Rosca-Rebaudengo P. Koro secondary to a tumour of the corpus callosum.Br J Psychiatry. 1988;153:251-254.
[PubMed] [DOI][Cited in This Article: ]
de Bures I, Houillon G, Debaisieux T, Hennebique JM. Detection of a brain tumor during a psychiatric evaluation.Ann Med Psychol (Paris). 1982;140:453-457.
[PubMed] [DOI][Cited in This Article: ]